Entasis Therapeutics Holdings Stock Forecast for 2023 - 2025 - 2030
Updated on 05/08/2024
Entasis Therapeutics Holdings Stock Forecast and Price Target
If Entasis Therapeutics Holdings's stock price reached the average yearlong target of $0.00 given by well-known analysts in recent months, there would be a potential downside of approximately -,100% from its last closing price in July, 2022. This potential increase is based on a high estimate of $0.00 and a low estimate of $0.00. If you're looking to buy Entasis Therapeutics Holdings stock, you may also want to check out its rivals.
N/A
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ABBV Stock Forecast | AbbVie | Outperform |
9
|
$162.55 | Buy/Sell | $178.42 | 10.74% |
| AMGN Stock Forecast | Amgen | Outperform |
4
|
$300.30 | Buy/Sell | $303.65 | 6.56% |
| GILD Stock Forecast | Gilead Sciences Inc | Outperform |
11
|
$65.46 | Buy/Sell | $87.82 | 22.21% |
| ALXN Stock Forecast | Alexion Pharmaceuticals | - |
0
|
$182.50 | Buy/Sell | $177.38 | -100.00% |
| BIIB Stock Forecast | Biogen | Outperform |
10
|
$218.92 | Buy/Sell | $299.62 | 31.78% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BMRN Stock Forecast | BioMarin Pharmaceutical | Outperform |
10
|
$82.58 | Buy/Sell | $111.56 | 33.20% |
| INCY Stock Forecast | Incyte | Outperform |
9
|
$54.37 | Buy/Sell | $77.05 | 44.38% |
| VKTX Stock Forecast | Viking Therapeutics | Buy |
5
|
$79.61 | Buy/Sell | $34.00 | 44.45% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BPMC Stock Forecast | Blueprint Medicines | Outperform |
6
|
$108.55 | Buy/Sell | $85.71 | 10.09% |
| ARNA Stock Forecast | Arena Pharmaceuticals | - |
6
|
$99.99 | Buy/Sell | $100.00 | -100.00% |
| CCXI Stock Forecast | ChemoCentryx | - |
8
|
$51.99 | Buy/Sell | $52.00 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CBAY Stock Forecast | CymaBay Therapeutics | Hold |
8
|
$32.44 | Buy/Sell | $27.73 | -100.00% |
| IOVA Stock Forecast | Iovance Biotherapeutics | Buy |
4
|
$13.98 | Buy/Sell | $20.42 | 82.40% |
| ARWR Stock Forecast | Arrowhead Pharmaceuticals | Outperform |
7
|
$25.00 | Buy/Sell | $52.00 | 120.00% |
Entasis Therapeutics Holdings EBITDA Forecast for 2023 - 2025 - 2030
In the last year, Entasis Therapeutics Holdings's EBITDA has gone down from $-54.09M to $-52.21M – a 3.48% drop. In the next year, analysts expect EBITDA to reach $-54.09M – an increase of 3.60%. For the next nine years, the forecast is for EBITDA to grow by 2.42%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DRNA Stock Forecast | Dicerna Pharmaceuticals | - |
7
|
$38.01 | Buy/Sell | $35.06 | -100.00% |
| FOLD Stock Forecast | Amicus Therapeutics | Outperform |
7
|
$10.42 | Buy/Sell | $17.90 | 91.94% |
| ACAD Stock Forecast | ACADIA Pharmaceuticals | Outperform |
6
|
$17.25 | Buy/Sell | $33.78 | 73.91% |
Entasis Therapeutics Holdings EBIT Forecast for 2023 - 2025 - 2030
In the last year, Entasis Therapeutics Holdings's EBIT has fallen from $-54.23M to $-52.32M – a 3.52% decrease. The next year looks promising for Entasis Therapeutics Holdings, with analysts predicting EBIT of $-54.23M – an increase of 3.65%. Over the next nine years, experts anticipate that Entasis Therapeutics Holdings's EBIT will grow at a rate of 2.45%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CLDX Stock Forecast | Celldex Therapeutics | Buy |
11
|
$42.21 | Buy/Sell | $63.29 | 68.21% |
| VCEL Stock Forecast | Vericel | Buy |
8
|
$49.52 | Buy/Sell | $42.58 | 11.07% |
| ARDX Stock Forecast | Ardelyx | Buy |
11
|
$9.31 | Buy/Sell | $9.94 | 50.38% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AGIO Stock Forecast | Agios Pharmaceuticals | Outperform |
9
|
$32.80 | Buy/Sell | $40.00 | 35.67% |
| DVAX Stock Forecast | Dynavax Technologies | Outperform |
11
|
$11.76 | Buy/Sell | $25.00 | 108.33% |
| ADMA Stock Forecast | ADMA Biologics | Buy |
9
|
$6.91 | Buy/Sell | $6.00 | 15.77% |
Site Navigation
.jpg)